%0 Journal Article
%T Reply
%A Anne M. Fitzpatrick
%A Daniel J. Jackson
%A David Mauger
%A Stanley J. Szefler
%J Journal of Allergy and Clinical Immunology
%D 2017
%R 10.1016/j.jaci.2017.06.018
%X Longo et£¿al1 raise an interesting issue regarding the differentiation of eosinophilic
asthma that may be nonatopic in nature. As indicated in our study, the likelihood
of a favorable response to daily inhaled corticosteroid therapy in young children
with emerging asthma was associated with either a blood eosinophil count of greater
than or equal to 300£¿cells/mm3 or allergic sensitization as defined by multiallergen
testing.2 The combination of these 2 features enhanced the likelihood of a favorable
response as compared with our other 2 treatment strategies, either daily oral montelukast
or inhaled corticosteroid administered with albuterol at the time of symptoms.
%U https://www.jacionline.org/article/S0091-6749(17)31096-5/abstract